FULC vs. BIOX

In the year-to-date period, FULC achieves a 48.09% return, which is significantly higher than BIOX's -21.05% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Fulcrum Therapeutics, Inc. (FULC) and Bioceres Crop Solutions Corp. (BIOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current FULC Sharpe Ratio is -0.11, which is higher than the BIOX Sharpe Ratio of -1.00. The chart below compares the historical Sharpe Ratios of FULC and BIOX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither FULC nor BIOX has paid dividends to shareholders.

The maximum FULC drawdown since its inception was -92.70%, which is greater than BIOX's maximum drawdown of -76.88%. Use the drawdown chart below to compare losses from any high point for FULC and BIOX.

Fulcrum Therapeutics, Inc. (FULC) has a higher volatility of 34.41% compared to Bioceres Crop Solutions Corp. (BIOX) at 20.64%. This indicates that FULC's price experiences larger fluctuations and is considered to be riskier than BIOX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Fulcrum Therapeutics, Inc. and Bioceres Crop Solutions Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.